Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzymes02:34

Enzymes

93.9K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
93.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.4K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.4K
Enzyme Kinetics01:19

Enzyme Kinetics

103.8K
Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
103.8K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

86.2K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.2K
What is Natural Selection?01:32

What is Natural Selection?

126.0K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
126.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular mechanisms and therapeutic targets in lung cancer-nerve crosstalk.

Chinese medical journal pulmonary and critical care medicine·2026
Same author

A case study of proteomics-guided personalized targeted therapy.

Science China. Life sciences·2026
Same author

PyNeon: A Python package for the analysis of Neon multimodal mobile eye-tracking data.

Behavior research methods·2026
Same author

HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence.

Journal for immunotherapy of cancer·2026
Same author

Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities.

Journal of translational medicine·2026
Same author

Intermediate accumulated upon interruption of fatty acid oxidation flux promotes tumoral ferroptosis and improves immunotherapy.

Nature communications·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

High-throughput Screening of Carbohydrate-degrading Enzymes Using Novel Insoluble Chromogenic Substrate Assay Kits
06:51

High-throughput Screening of Carbohydrate-degrading Enzymes Using Novel Insoluble Chromogenic Substrate Assay Kits

Published on: September 20, 2016

13.6K

Substrate-Selective Enzyme Inhibitors.

Qian Chu1, Tina Chang1, Alan Saghatelian1

  • 1The Salk Institute for Biological Studies, Clayton Foundation Laboratories for Peptide Biology, 10010 N. Torrey Pines Rd, La Jolla, CA 92037, USA.

Trends in Pharmacological Sciences
|August 7, 2019
PubMed
Summary
This summary is machine-generated.

Researchers discovered new ways to target enzymes with multiple substrates, like insulin-degrading enzymes (IDE), reducing potential side effects. This breakthrough offers new therapeutic strategies for drug development.

Keywords:
chemical biologyenzyme reprogrammingexo siteinsulin-degrading enzymesubstrate-selective inhibition

More Related Videos

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
10:43

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes

Published on: October 3, 2019

6.4K
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
08:10

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Published on: August 8, 2016

9.3K

Related Experiment Videos

Last Updated: Jan 21, 2026

High-throughput Screening of Carbohydrate-degrading Enzymes Using Novel Insoluble Chromogenic Substrate Assay Kits
06:51

High-throughput Screening of Carbohydrate-degrading Enzymes Using Novel Insoluble Chromogenic Substrate Assay Kits

Published on: September 20, 2016

13.6K
Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
10:43

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes

Published on: October 3, 2019

6.4K
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
08:10

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Published on: August 8, 2016

9.3K

Area of Science:

  • Biochemistry
  • Enzyme kinetics
  • Drug discovery

Background:

  • Enzymes processing multiple substrates present drug development challenges due to potential on-target side effects.
  • Insulin-degrading enzyme (IDE) is a key example of a multi-substrate enzyme implicated in various physiological and pathological processes.

Purpose of the Study:

  • To identify novel inhibitors targeting exo-sites of insulin-degrading enzymes (IDE).
  • To investigate the potential of these inhibitors in altering IDE's substrate selectivity.
  • To explore new therapeutic avenues for drugging multi-substrate enzymes.

Main Methods:

  • Utilized biochemical assays to screen for exo-site inhibitors of IDE.
  • Characterized the binding kinetics and selectivity profiles of identified inhibitors.
  • Investigated the impact of inhibitor binding on IDE's enzymatic activity towards different substrates.

Main Results:

  • Identified novel small-molecule inhibitors that bind to exo-sites of IDE.
  • Demonstrated that these inhibitors can modulate IDE's substrate selectivity.
  • Showcased a new strategy for developing targeted therapeutics for multi-substrate enzymes.

Conclusions:

  • Exo-site inhibition is a viable strategy for modulating the activity and selectivity of multi-substrate enzymes like IDE.
  • This research opens new avenues for developing safer and more effective drugs by minimizing on-target side effects.
  • The findings redefine the understanding of how to therapeutically target enzymes with broad substrate specificities.